|
At least 40% of attempts at sexual intercourse successful |
|||||
| Number (%) with outcome |
|||||
|
|
|||||
| Dosing (mg) |
Number of trials |
Sildenafil |
Placebo |
Relative benefit (95% CI) |
NNT (95% CI) |
|
|
|||||
| 25 |
3 |
122/312 (39) |
70/426 (16) |
2.6 (2.0 to 3.3) |
4.4 (3.4 to 6.2) |
| 50 |
5 |
269/511 (53) |
102/607 (17) |
3.3 (2.7 to 4.0) |
2.8 (2.4 to 3.3) |
| 100 |
5 |
272/506 (54) |
102/607 (17) |
3.3 (2.7 to 4.1) |
2.7 (2.4 to 3.2) |
| 200 |
2 |
106/191 (55) |
32/181 (18) |
3.1 (2.2 to 4.3) |
2.6 (2.1 to 3.5) |
| Dose optimised |
3 |
227/379 (60) |
70/376 (19) |
3.2 (2.6 to 4.0) |
2.4 (2.1 to 2.9) |
Moore et al. BMC Urology 2002 2:6 doi:10.1186/1471-2490-2-6 |
|||||